PSM retrospective 1,620 hospitalized patients in the USA, 84 with existing famotidine use, showing lower risk of combined death/intubation with treatment.
risk of death/intubation, 57.0% lower, RR 0.43, p = 0.02, treatment 8 of 84 (9.5%), control 332 of 1,536 (21.6%), NNT 8.3, propensity score matching.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Freedberg et al., 21 May 2020, retrospective, propensity score matching, USA, peer-reviewed, 15 authors.
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
See Covering the Cover synopsis on page 803.
Supplementary Material Note: To access the supplementary material accompanying this article, visit the online version of Gastroenterology at www.gastrojournal.org, and at https://doi.org/10.1053/ j.gastro.2020.05.053.
Anand, Ziebuhr, Wadhwani, None, Science
Bourinbaiar, Fruhstorfer, None, Life Sci
Chen, Deng, Churchill, None, Cell Stem Cell
Gottschlich, Delegge, Guenter, American Society for Parenteral and Enteral Nutrition
Li, Zhang, Liu, Gu, None, FASEB J
Wu, Liu, Yang, None, Acta Pharm Sin B